SCHEMBL6415283

SCHEMBL6415283

O=C(NCc1cccs1)OC1=NOC2(CCN(C(=O)CCCOc3ccccc3)CC2)C1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.45
SMN1; SMN2 Q16637 7/20 0.43
NPC1 O15118 7/20 0.43
RAB9A P51151 7/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 4/20 0.42
GAA P10253 2/20 0.42
ALDH1A1 P00352 5/20 0.40
TSHR P16473 5/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 2/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
POLB P06746 1/20 0.38
METAP2 P50579 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2405040 0.87 PKM (0.47) PKMSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL6411868 0.84 NPC1 (0.46) SMN1; SMN2NPC1RAB9AHPGDMAPT
SCHEMBL6419550 0.83 RAB9A (0.54) PKMSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL6413986 0.82 FKBP1A (0.46) RAB9AHPGDMAPTGAAALDH1A1
SCHEMBL6412136 0.80 SMN1; SMN2 (0.39) SMN1; SMN2NPC1RAB9AHPGDGAA
SCHEMBL6431092 0.79 AVPR1A (0.41) SMN1; SMN2ALDH1A1MAPK1KDM4ELMNA
SCHEMBL6411043 0.79 SMN1; SMN2 (0.41) PKMSMN1; SMN2RAB9AHPGDMAPT
SCHEMBL6415977 0.78 ABL1 (0.41) SMN1; SMN2HPGDALDH1A1KMT2ALMNA
SCHEMBL6410752 0.77 USP7 (0.39) PKMSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL6411592 0.76 POLB (0.41) PKMRAB9AHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed